- Cell Biology
- Product Type
- Research Area
- New Products
- About Tocris
- Contact Us
The Tocriscreen™ range of compound libraries are collections of compounds designed for use in screening assays for receptor de-orphaning, target validation, drug re-profiling, tool compound identification and also assay development. Comprised of biologically active compounds selected from the Tocris catalog, these libraries provide wide coverage of cellular targets, including GPCRs, ion channels, kinases, enzymes, nuclear receptors and transporters.
Tocriscreen 2.0 Max, Mini and Micro Compound Libraries are composed of 1280 compounds, covering multiple pharmacological targets and research areas. Collections of compounds for specific research areas or targets, such as Epigenetics and Kinases, are also available.
To request the detailed compound lists for any of the Tocriscreen compound libraries, please complete the compound library inquiry form.
|2.0 Micro (Cat. No. 7152)||2.0 Mini (Cat. No. 7151)||2.0 Max (Cat. No. 7150)|
|No. of Compounds||1280||1280||1280|
|Volume||15 μL||50 μL||250 μL|
|Solution Format||10 mM DMSO||10 mM DMSO||10 mM DMSO|
|Seal||Peelable foil seal||SepraSeal Cap||SepraSeal Cap|
|Storage Format||96-well, v-bottom microplate||96-well racks with Matrix™ storage tubes||96-well racks with Matrix™ storage tubes|
|Stability (for at least)||6 months, prior to opening||6 months||6 months|
The Tocriscreen PRO service is a unique custom compound library service, which enables you to cherry-pick from >3600 compounds available in the Tocris catalog, to create a library designed to meet your exact screening requirements. The Tocris scientific team can provide assistance in choosing compounds that are relevant to your research requirements. Contact us today to discuss your needs via the compound library inquiry form.
The Tocriscreen epigenetics compound library consist of collection of 101 compounds with proven activity against over 40 epigenetic targets. This blog post provides further details about this bioactive compound library, and also outlines an example of how a compound library can be used for target validation.Read Now!
This webinar brings together experts to discuss chemical genomics and the advances and promises it brings to therapeutic discovery. The use of compound libraries and the possibilities for drug repurposing are examined, and the potential of patient lead approaches to identify novel targets with chemical genomics are considered.Watch Now!